Playback speed
10 seconds
ESMO 2024 Insights: RELATIVITY-104 Study - Nivo + Relatlimab With Platinum-Doublet Chemo vs. Nivo + Platinum-Doublet Chemo as 1L Treatment for Stage IV or Recurrent NSCLC
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Nicolas Girard
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Nicolas Girard
31 views
September 18, 2024
Login to view comments.
Click here to Login